BlackRock Fund Advisors’s Alder Biopharmaceuticals ALDR Stock Holding History

BlackRock Fund Advisors’s Portfolio ALDR Stock Details ALDR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$44.4M	Buy	2,133,222 +278,278	+15%	+$7.24M	0.01%	1759
2016 Q3	$60.8M	Buy	1,854,944 +100,431	+6%	+$3.06M	0.01%	1439
2016 Q2	$43.8M	Buy	1,754,513 +617,690	+54%	+$16.7M	0.01%	1581
2016 Q1	$27.8M	Buy	1,136,823 +45,908	+4%	+$1.06M	0.01%	1795
2015 Q4	$36M	Sell	1,090,915 -82,739	-7%	-$2.8M	0.01%	1701
2015 Q3	$38.4M	Buy	1,173,654 +195,017	+20%	+$8.29M	0.01%	1589
2015 Q2	$51.8M	Buy	978,637 +224,075	+30%	+$8.15M	0.01%	1506
2015 Q1	$21.8M	Buy	754,562 +170,980	+29%	+$4.69M	0.01%	2025
2014 Q4	$17M	Buy	583,582 +394,513	+209%	+$7.08M	﹤0.01%	2159
2014 Q3	$2.4M	Sell	189,069 -7,839	-4%	-$118K	﹤0.01%	3095
2014 Q2	$3.95M	Buy	+196,908	New	+$2.77M	﹤0.01%	2961

Other funds holding ALDR

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.17B AUM 92.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

FCMI

Foresite Capital Management III Larkspur, California $37.9M AUM 6.87% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

BlackRock Fund Advisors's ALDR Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Alder Biopharmaceuticals (ALDR) stake by 15% in Q4 2016, buying an estimated $7.24M and bringing the position to 2,133,222 shares worth $44.4M. The position accounts for 0.01% of the portfolio, ranked #1759.

BlackRock Fund Advisors first reported a position in ALDR in Q2 2014 and has held it in 11 quarters since. The position peaked at $60.8M in Q3 2016. 145 funds tracked by Wall St. Rank hold ALDR as of Q4 2016.

BlackRock Fund Advisors held 2,133,222 shares of Alder Biopharmaceuticals worth $44.4M as of Q4 2016.
BlackRock Fund Advisors bought 278,278 Alder Biopharmaceuticals shares in Q4 2016, an estimated $7.24M.
Alder Biopharmaceuticals made up 0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #1759 holding.
BlackRock Fund Advisors first reported a position in Alder Biopharmaceuticals in Q2 2014 and has held it in 11 quarters since.
BlackRock Fund Advisors's Alder Biopharmaceuticals position peaked at $60.8M in Q3 2016.
145 funds tracked by Wall St. Rank held Alder Biopharmaceuticals as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.